Records 1-30 (of 237 Records) |
Query Trace: Disparities[original query] |
---|
Vaccination, human mobility, and COVID-19 health outcomes: Empirical comparison before and during the outbreak of SARS-Cov-2 B.1.1.529 (Omicron) variant. Hu Songhua, et al. Vaccine 2023 0 0. ![]() ![]() ![]() ![]() ![]() |
Modeling the Lassa fever outbreak synchronously occurring with cholera and COVID-19 outbreaks in Nigeria 2021: A threat to Global Health Security. Tahmo Nancy B, et al. PLOS global public health 2023 0 0. (5) e0001814 ![]() ![]() |
A study of disparities in access to genetic care pre- and post-pandemic. Macalino Ashlee Joan, et al. American journal of medical genetics. Part A 2023 0 0. ![]() ![]() |
School-Based Interventions to Increase Student COVID-19 Vaccination Coverage in Public School Populations with Low Coverage - Seattle, Washington, December 2021-June 2022. Tarayn Fairlie et al. MMWR. Morbidity and mortality weekly report 2023 3 (11) 283-287 ![]() ![]() ![]() ![]()
Vaccination decreases risk for COVID-19 illness, severe disease, and death. U.S. pediatric COVID-19 vaccination coverage remains low. Seattle Public Schools implemented a COVID-19 vaccination program through multiple community engagements. During December 2021–June 2022, completion of the primary COVID-19 vaccination series among Seattle Public Schools students aged 5–18 years increased from 56.5% to 80.3%.
|
Global Human Threat: The Potential Synergism between Mercury Intoxication and COVID-19. Arrifano Gabriela de Paula, et al. International journal of environmental research and public health 2023 0 0. (5) ![]() ![]() |
Association of the ACE and AGT gene polymorphisms with global disparities in COVID-19-related deaths. Saab Yolande B, et al. Pharmacogenetics and genomics 2023 0 0. ![]() ![]() ![]() |
Bayesian Spatio-Temporal Prediction and Counterfactual Generation: An Application in Non-Pharmaceutical Interventions in COVID-19. Lawson Andrew, et al. Viruses 2023 0 0. (2) ![]() ![]() |
Epigenetic Targets and Pathways Linked to SARS-CoV-2 Infection and Pathology. Rabaan Ali A, et al. Microorganisms 2023 0 0. (2) ![]() |
Telehealth utilization in U.S. medicare beneficiaries aged 65 years and older during the COVID-19 pandemic. Lu Min, et al. BMC public health 2023 0 0. (1) 368 ![]() ![]() |
Use of the improvement index to evaluate equitable COVID-19 vaccine allocation in the San Francisco Bay Area. Jumamil Riana B, et al. AJPM focus 2023 0 0. 100075 ![]() ![]() ![]() |
Socioexposomics of COVID-19 across New Jersey: a comparison of geostatistical and machine learning approaches. Ren Xiang, et al. Journal of exposure science & environmental epidemiology 2023 0 0. ![]() |
Inequities in COVID-19 vaccine and booster coverage across Massachusetts ZIP codes after the emergence of Omicron: A population-based cross-sectional study. Jacob Bor et al. PLoS medicine 2023 1 (1) e1004167 ![]() ![]() ![]()
We analyzed data on 418 ZIP codes. We observed wide geographic variation in primary series vaccination and booster rates, with marked inequities by ZIP code-level education, median household income, essential worker share, and racial/ethnic composition. In age-stratified analyses, primary series vaccine coverage was very high among the elderly. However, we found large inequities in vaccination rates among younger adults and children, and very large inequities in booster rates for all age groups.
|
Risk Factors for Reinfection with SARS-CoV-2 Omicron Variant among Previously Infected Frontline Workers. Ellingson Katherine D, et al. Emerging infectious diseases 2023 0 0. (3) ![]() ![]() ![]() ![]() |
SARS-CoV-2 chronological genomic evolution and epidemiology in the Middle East and North Africa (MENA) region as affected by vaccination, conflict and socioeconomical disparities: a population-based cohort study. Obeid Dalia et al. BMJ open 2023 1 (9) e060775 ![]() ![]() ![]() ![]() |
Incentivizing COVID-19 vaccination among racial/ethnic minority adults in the United States: $209 per dose could convince the hesitant. Chen Kevin, et al. Health economics review 2023 0 0. (1) 4 ![]() ![]() ![]() |
SARS-CoV-2 seroprevalence in children worldwide: A systematic review and meta-analysis. Naeimi Reza, et al. EClinicalMedicine 2023 0 0. 101786 ![]() ![]() ![]() ![]() |
COVID-19 Diagnosis on Chest Radiograph Using Artificial Intelligence. Baruah Dhiraj, et al. Cureus 2022 0 0. (11) e31897 ![]() |
Disparities in patient portal access by US adults before and during the COVID-19 pandemic. Nishii Akira, et al. JAMIA open 2022 0 0. (4) ooac104 ![]() ![]() |
Population Risk Factors for Severe Disease and Mortality in COVID-19 in the United States during the Pre-Vaccine Era: A Retrospective Cohort Study of National Inpatient Sample. Raj Kavin, et al. Medical sciences (Basel, Switzerland) 2022 0 0. (4) ![]() ![]() ![]() |
Determining Gaps in Publicly Shared SARS-CoV-2 Genomic Surveillance Data by Analysis of Global Submissions. Ohlsen Elizabeth C, et al. Emerging infectious diseases 2022 0 0. (13) 85-92 ![]() |
Associations between area-level health-related social factor indices and risk of acute COVID-19: An EHR-based cohort study from the RECOVER program DJ Chisolm et al, MEDRXIV, December 3, 2022 ![]() ![]()
Both area deprivation index (ADI) and child opportunity index (COI) were significantly associated with COVID-19 positivity in univariate and adjusted models, particularly in the pre-delta and delta variant waves. ADI showed a stronger association. Higher rates of positivity were found for non-Hispanic Black, Hispanic, and multi-racial children compared to non-Hispanic White children. These racial disparities remained significant after control for either index and other variables.
|
Advancing disease genomics beyond COVID-19 and reducing health disparities: what does the future hold for Africa? Ibe Chibuike, et al. Briefings in functional genomics 2022 0 0. ![]() ![]() |
A sample-to-answer COVID-19 diagnostic device based on immiscible filtration and CRISPR-Cas12a-assisted detection. Ngamsom Bongkot, et al. Talanta open 2022 0 0. 100166 ![]() ![]() |
Global disparities in SARS-CoV-2 genomic surveillance. Brito Anderson F et al. Nature communications 2022 11 (1) 7003 ![]() ![]() ![]() ![]() ![]()
In the first two years of the pandemic, 78% of high-income countries sequenced >0.5% of their COVID-19 cases, while 42% of low- and middle-income countries reached that mark. Around 25% of the genomes from high income countries were submitted within 21 days, a pattern observed in 5% of the genomes from low- and middle-income countries. We found that sequencing around 0.5% of the cases, with a turnaround time <21 days, could provide a benchmark for SARS-CoV-2 genomic surveillance. Socioeconomic inequalities undermine the global pandemic preparedness.
|
mRNA Vaccination Decreases COVID-19-Associated Morbidity and Mortality Among Organ Transplant Recipients: A Contemporary Cohort Study. Lerner Alexis Hope, et al. Open forum infectious diseases 2022 0 0. (10) ofac503 ![]() ![]() ![]() |
Racial and Ethnic Disparities in Outpatient Treatment of COVID-19 - United States, January-July 2022. Boehmer Tegan K et al. MMWR. Morbidity and mortality weekly report 2022 10 (43) 1359-1365 ![]() ![]() ![]()
Outpatient medications are effective at preventing severe COVID-19 and are important to pandemic mitigation. Paxlovid is the most commonly prescribed medication and the preferred outpatient therapeutic for eligible patients. Racial and ethnic disparities persisted in outpatient COVID-19 treatment through July 2022. During April–July 2022, the percentage of COVID-19 patients aged =20 years treated with Paxlovid was 36% and 30% lower among Black and Hispanic patients than among White and non-Hispanic patients, respectively. These disparities existed among all age groups and patients with immunocompromise.
|
Development of Single-Cell Transcriptomics and Its Application in COVID-19. Wang Chaochao, et al. Viruses 2022 0 0. (10) ![]() ![]() ![]() |
American Twitter users revealed social determinant-related oral health disparities amid the COVID-19 pandemic. Fan Yangxin, et al. Quintessence international (Berlin, Germany : 1985) 2022 0 0. (0) 2-14 ![]() ![]() |
Serological responses to human virome define clinical outcomes of Italian patients infected with SARS-CoV-2. Wang Limin, et al. International journal of biological sciences 2022 0 0. (15) 5591-5606 ![]() ![]() ![]() |
Racial Disparities in Pulse Oximeter Device Inaccuracy and Estimated Clinical Impact on COVID-19 Treatment Course. Sudat Sylvia E K et al. American journal of epidemiology 2022 9 ![]() ![]() ![]()
Pulse oximetry systematically overestimated blood oxygenation by 1% more in NHB individuals than in NHW individuals. For people with COVID-19, this was associated with lower admission probability (-3.1 percentage-points), dexamethasone treatment (-3.1 percentage-points), and supplemental oxygen treatment (-4.5 percentage-points), as well as increased time-to-treatment: +37.2 minutes before dexamethasone initiation and +278.5 minutes before initiation of supplemental oxygen.
|
Disclaimer: Articles listed in the Public Health
Knowledge Base are selected by the CDC Office of Public Health
Genomics to provide current awareness of the literature and news.
Inclusion in the update does not necessarily represent the views of
the Centers for Disease Control and Prevention nor does it imply
endorsement of the article's methods or findings. CDC and DHHS assume
no responsibility for the factual accuracy of the items presented. The
selection, omission, or content of items does not imply any
endorsement or other position taken by CDC or DHHS. Opinion, findings
and conclusions expressed by the original authors of items included in
the update, or persons quoted therein, are strictly their own and are
in no way meant to represent the opinion or views of CDC or DHHS.
References to publications, news sources, and non-CDC Websites are
provided solely for informational purposes and do not imply
endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2023
- Page last updated:Jun 08, 2023
- Content source: